| pubmed-article:9652451 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9652451 | lifeskim:mentions | umls-concept:C0019682 | lld:lifeskim |
| pubmed-article:9652451 | lifeskim:mentions | umls-concept:C0027361 | lld:lifeskim |
| pubmed-article:9652451 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:9652451 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
| pubmed-article:9652451 | lifeskim:mentions | umls-concept:C0242629 | lld:lifeskim |
| pubmed-article:9652451 | lifeskim:mentions | umls-concept:C0003320 | lld:lifeskim |
| pubmed-article:9652451 | lifeskim:mentions | umls-concept:C0030956 | lld:lifeskim |
| pubmed-article:9652451 | lifeskim:mentions | umls-concept:C0262514 | lld:lifeskim |
| pubmed-article:9652451 | lifeskim:mentions | umls-concept:C0332185 | lld:lifeskim |
| pubmed-article:9652451 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:9652451 | pubmed:dateCreated | 1998-7-27 | lld:pubmed |
| pubmed-article:9652451 | pubmed:abstractText | The combination of a tumor necrosis factor (TNF)-alpha enzyme-linked immunospot (ELISPOT) assay and computer-assisted video image analysis was used to detect and quantitate in peripheral blood CD8+ T cells reactive with known human immunodeficiency virus type 1 (HIV-1) peptide antigens presented by HLA-A2 or HLA-A3. T lymphocyte responsiveness to at least one HIV peptide was found in 10 (83%) of 12 HIV-1-infected patients and in 5 (45%) of 11 persons who had no serologic and virologic signs of HIV infection but who were at high risk for recent sexual exposure to HIV-1. CD8+ T cells responding to HIV-1 peptides were observed in none of 11 HIV-seronegative donors without a history of HIV exposure. ELISPOT assays are relatively fast and easy to perform and appear to reliably detect T cell reactivity due to previous exposure to HIV. These findings support the use of the ELISPOT assay for monitoring T cell responsiveness to HIV peptides. | lld:pubmed |
| pubmed-article:9652451 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9652451 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9652451 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:9652451 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9652451 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9652451 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9652451 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9652451 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9652451 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9652451 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9652451 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:9652451 | pubmed:issn | 0022-1899 | lld:pubmed |
| pubmed-article:9652451 | pubmed:author | pubmed-author:Meyer zum... | lld:pubmed |
| pubmed-article:9652451 | pubmed:author | pubmed-author:HerrWW | lld:pubmed |
| pubmed-article:9652451 | pubmed:author | pubmed-author:GerkenGG | lld:pubmed |
| pubmed-article:9652451 | pubmed:author | pubmed-author:LohseA WAW | lld:pubmed |
| pubmed-article:9652451 | pubmed:author | pubmed-author:WölfelTT | lld:pubmed |
| pubmed-article:9652451 | pubmed:author | pubmed-author:ProtzerUU | lld:pubmed |
| pubmed-article:9652451 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9652451 | pubmed:volume | 178 | lld:pubmed |
| pubmed-article:9652451 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9652451 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9652451 | pubmed:pagination | 260-5 | lld:pubmed |
| pubmed-article:9652451 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:9652451 | pubmed:meshHeading | pubmed-meshheading:9652451-... | lld:pubmed |
| pubmed-article:9652451 | pubmed:meshHeading | pubmed-meshheading:9652451-... | lld:pubmed |
| pubmed-article:9652451 | pubmed:meshHeading | pubmed-meshheading:9652451-... | lld:pubmed |
| pubmed-article:9652451 | pubmed:meshHeading | pubmed-meshheading:9652451-... | lld:pubmed |
| pubmed-article:9652451 | pubmed:meshHeading | pubmed-meshheading:9652451-... | lld:pubmed |
| pubmed-article:9652451 | pubmed:meshHeading | pubmed-meshheading:9652451-... | lld:pubmed |
| pubmed-article:9652451 | pubmed:meshHeading | pubmed-meshheading:9652451-... | lld:pubmed |
| pubmed-article:9652451 | pubmed:meshHeading | pubmed-meshheading:9652451-... | lld:pubmed |
| pubmed-article:9652451 | pubmed:meshHeading | pubmed-meshheading:9652451-... | lld:pubmed |
| pubmed-article:9652451 | pubmed:meshHeading | pubmed-meshheading:9652451-... | lld:pubmed |
| pubmed-article:9652451 | pubmed:meshHeading | pubmed-meshheading:9652451-... | lld:pubmed |
| pubmed-article:9652451 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9652451 | pubmed:articleTitle | Quantification of CD8+ T lymphocytes responsive to human immunodeficiency virus (HIV) peptide antigens in HIV-infected patients and seronegative persons at high risk for recent HIV exposure. | lld:pubmed |
| pubmed-article:9652451 | pubmed:affiliation | I. Medizinische Klinik und Poliklinik, Johannes Gutenberg-Universität Mainz, Germany. | lld:pubmed |
| pubmed-article:9652451 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9652451 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9652451 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9652451 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9652451 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9652451 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9652451 | lld:pubmed |
